SE405121B - Forfarande for framstellning av 2-(heteroaryl-metyl)-5-9beta-dialkyl-6,7-bensomorfaner eller deras syraadditionssalter - Google Patents

Forfarande for framstellning av 2-(heteroaryl-metyl)-5-9beta-dialkyl-6,7-bensomorfaner eller deras syraadditionssalter

Info

Publication number
SE405121B
SE405121B SE7308564A SE7308564A SE405121B SE 405121 B SE405121 B SE 405121B SE 7308564 A SE7308564 A SE 7308564A SE 7308564 A SE7308564 A SE 7308564A SE 405121 B SE405121 B SE 405121B
Authority
SE
Sweden
Prior art keywords
benzomorphanes
9beta
dialkyl
heteroaryl
methyl
Prior art date
Application number
SE7308564A
Other languages
English (en)
Swedish (sv)
Inventor
H Merz
A Langbein
K Stockhaus
H Wick
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of SE405121B publication Critical patent/SE405121B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SE7308564A 1972-06-19 1973-06-18 Forfarande for framstellning av 2-(heteroaryl-metyl)-5-9beta-dialkyl-6,7-bensomorfaner eller deras syraadditionssalter SE405121B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2229695A DE2229695A1 (de) 1972-06-19 1972-06-19 2-(heteroaryl-methyl)-5,9 beta-dialkyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
SE405121B true SE405121B (sv) 1978-11-20

Family

ID=5848060

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7308564A SE405121B (sv) 1972-06-19 1973-06-18 Forfarande for framstellning av 2-(heteroaryl-metyl)-5-9beta-dialkyl-6,7-bensomorfaner eller deras syraadditionssalter

Country Status (13)

Country Link
US (1) US3931194A (US08088918-20120103-C00476.png)
JP (1) JPS5711908B2 (US08088918-20120103-C00476.png)
AT (6) AT329200B (US08088918-20120103-C00476.png)
BE (1) BE801079A (US08088918-20120103-C00476.png)
CH (9) CH589649A5 (US08088918-20120103-C00476.png)
DE (1) DE2229695A1 (US08088918-20120103-C00476.png)
DK (1) DK136904C (US08088918-20120103-C00476.png)
ES (8) ES416037A1 (US08088918-20120103-C00476.png)
FR (1) FR2189056B1 (US08088918-20120103-C00476.png)
GB (1) GB1433817A (US08088918-20120103-C00476.png)
NL (1) NL7308483A (US08088918-20120103-C00476.png)
NO (1) NO137694C (US08088918-20120103-C00476.png)
SE (1) SE405121B (US08088918-20120103-C00476.png)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2437610A1 (de) * 1974-08-05 1976-02-26 Boehringer Sohn Ingelheim Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung
GB1575009A (en) * 1976-06-21 1980-09-17 Acf Chemiefarma Nv 6,7-benzomorphan derivatives
JPS63177704A (ja) * 1987-01-16 1988-07-21 松山株式会社 農作業機連結装置
CL2008002199A1 (es) 2007-07-26 2009-10-23 Vitae Pharmaceuticals Inc Compuestos derivados de 1,3-oxazin-2-ona; composicion farmaceutica que comprende a dichos compuestos; y uso para tratar una enfermedad asociada con la actividad de la 11beta-hidroxiesteroide deshidrogenasa tipo 1 (11beta-hsd1) tales como dislipidemia, hiperlipidemia, hipertension, obesidad y enfermedad cardiovascular, entre otras.
AR069545A1 (es) * 2007-11-16 2010-02-03 Boehringer Ingelheim Pharma Derivados de aril y heteroarilcarbonilo de benzomorfanos y estructuras relacionadas, composiciones farmaceuticas que contienen dichos compuestos, obtencion de las mismas, su uso en el tratamiento de enfermedades mediadas por la inhibicion de la enzima 11beta-hidroxiesteroide deshidrogenasa (hsd) 1 y
JP5490014B2 (ja) 2007-12-11 2014-05-14 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1型の環状尿素阻害剤
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
EP2252601B1 (en) 2008-01-24 2012-12-19 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2009100872A1 (en) * 2008-02-12 2009-08-20 Boehringer Ingelheim International Gmbh Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
EP2254872A2 (en) 2008-02-15 2010-12-01 Vitae Pharmaceuticals, Inc. Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
CA2723034A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CL2009001058A1 (es) 2008-05-01 2010-09-10 Vitae Pharmaceuticals Inc Compuestos derivados de oxazinas sustituidas, inhibidores de la 11b-hidroxiesteroide deshidrogenasa de tipo-1; composicion farmaceutica; y uso del compuesto para inhibir la actividad de 11b-hsd1, como en el tratamiento de la diabetes, dislipidemia, hipertension, obesidad, cancer, glaucoma, entre otras.
BRPI0911764A2 (pt) 2008-05-01 2015-10-06 Boehringer Ingelheim Int inibidores cíclicos de 11beta-hidroxiesteroide desigrogenase 1
AR071719A1 (es) 2008-05-13 2010-07-07 Boehringer Ingelheim Int Derivados aliciclicos de acido carboxilico de benzomorfanos y estructuras relacionadas, medicamentos que contienen dichos compuestos y su uso.procesos de obtencion
US8114868B2 (en) 2008-07-25 2012-02-14 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
TW201016691A (en) 2008-07-25 2010-05-01 Boehringer Ingelheim Int Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
MA33216B1 (fr) 2009-04-30 2012-04-02 Boehringer Ingelheim Int Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1
US8927539B2 (en) 2009-06-11 2015-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure
AR078887A1 (es) * 2009-11-06 2011-12-07 Boehringer Ingelheim Int Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina y composiciones farmaceuticas que los contienen.
EP2582698B1 (en) 2010-06-16 2016-09-14 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基-及雜環芳基羰基衍生物
JP2014524438A (ja) 2011-08-17 2014-09-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング インデノピリジン誘導体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1281227A (fr) * 1958-09-22 1962-01-12 Smith Kline French Lab Perfectionnements apportés aux procédés pour la préparation de dérivés d'aralcoylbenzomorphane
BE582575A (US08088918-20120103-C00476.png) * 1958-09-22
CS166804B2 (US08088918-20120103-C00476.png) * 1971-02-08 1976-03-29 Boehringer Sohn Ingelheim
SE392895B (sv) * 1971-08-24 1977-04-25 Sumitomo Chemical Co Forfarande for framstellning av bensomorfanderivat och deras salter

Also Published As

Publication number Publication date
AT328629B (de) 1976-03-25
ATA489474A (de) 1975-06-15
ES431516A1 (es) 1976-11-16
DK136904B (da) 1977-12-12
CH589648A5 (US08088918-20120103-C00476.png) 1977-07-15
ES431515A1 (es) 1976-11-01
AT328628B (de) 1976-03-25
NO137694B (no) 1977-12-27
ATA489774A (de) 1975-06-15
CH589649A5 (US08088918-20120103-C00476.png) 1977-07-15
JPS4961170A (US08088918-20120103-C00476.png) 1974-06-13
CH583229A5 (US08088918-20120103-C00476.png) 1976-12-31
FR2189056B1 (US08088918-20120103-C00476.png) 1976-10-22
CH583231A5 (US08088918-20120103-C00476.png) 1976-12-31
CH583230A5 (US08088918-20120103-C00476.png) 1976-12-31
ES431514A1 (es) 1976-11-01
CH582697A5 (US08088918-20120103-C00476.png) 1976-12-15
NO137694C (no) 1978-04-05
NL7308483A (US08088918-20120103-C00476.png) 1973-12-21
ES431511A1 (es) 1976-11-01
ES431512A1 (es) 1976-11-01
AT329199B (de) 1976-04-26
BE801079A (fr) 1973-12-18
DE2229695A1 (de) 1974-01-31
ATA489874A (de) 1975-07-15
ATA489974A (de) 1975-07-15
ES416037A1 (es) 1976-02-16
JPS5711908B2 (US08088918-20120103-C00476.png) 1982-03-08
FR2189056A1 (US08088918-20120103-C00476.png) 1974-01-25
AU5704673A (en) 1974-12-19
GB1433817A (en) 1976-04-28
AT325218B (de) 1975-10-10
ES431510A1 (es) 1976-11-01
ES431513A1 (es) 1976-11-01
US3931194A (en) 1976-01-06
CH583227A5 (US08088918-20120103-C00476.png) 1976-12-31
AT328627B (de) 1976-03-25
AT329200B (de) 1976-04-26
CH583228A5 (US08088918-20120103-C00476.png) 1976-12-31
CH582698A5 (US08088918-20120103-C00476.png) 1976-12-15
ATA490074A (de) 1975-06-15
DK136904C (da) 1978-06-26

Similar Documents

Publication Publication Date Title
DK136714B (da) Analogifremgangsmåde til fremstilling af substituerede piperidinderivater eller syreadditionssalte deraf.
SE405121B (sv) Forfarande for framstellning av 2-(heteroaryl-metyl)-5-9beta-dialkyl-6,7-bensomorfaner eller deras syraadditionssalter
DK138496B (da) Analogifremgangsmåde til fremstilling af imidazolinderivater eller syreadditionssalte deraf.
DK136713B (da) Analogifremgangsmåde til fremstilling af alfa-aryl-4-substituerede piperidinoalkanolderivater eller deres syreadditionssalte.
DK131287B (da) Analogifremgangsmåde til fremstilling af 2-phenylimino-imidazolidiner eller syreadditionssalte deraf.
DK139575B (da) Analogifremgangsmåde til fremstilling af 2-aminomethylen-1-indanon-forbindelser eller syreadditionssalte deraf.
DK140545B (da) Analogifremgangsmåde til fremstilling af benzoylphenylsmørsyrederivater eller salte deraf.
DK131778B (da) Fremgangsmåde til fremstilling af substituerede 3-hydroksymetylisokinolinderivater eller syreadditionssalte heraf.
DK140833B (da) Analogifremgangsmåde til fremstilling af phenylethylaminderivater eller syreadditionssalte deraf.
DK138491B (da) Analogifremgangsmåde til fremstilling af N-(1-cyclohexyl-3-pyrrolidinyl)-benzamider eller syreadditionssalte deraf.
DK131857B (da) Analogifremgangsmåde til fremstilling af 4-hydroxymethyl-1-phthalazonderivater eller syreadditionssalte deraf.
DK138943B (da) Analogifremgangsmåde til fremstilling af substituerede dibenzocyclohepten-carboxamider eller syreadditionssalte deraf.
DK138117B (da) Analogifremgangsmåde til fremstilling af isoindolinderivater eller syreadditionssalte deraf.
DK136722B (da) Analogifremgangsmåde til fremstilling af oxazolidinon-(2)-derivater eller syreadditionssalte heraf.
DK130344B (da) Analogifremgangsmåde til fremstilling af benzofuranderivater eller syreadditionssalte deraf.
DK137757B (da) Analogifremgangsmåde til fremstilling af pyridylpiperaziner eller syreadditionssalte deraf.
DK134014B (da) Analogifremgangsmåde til fremstilling af cycloalkyllactamimider eller syreadditionssalte deraf.
DK133677B (da) Analogifremgangsmåde til fremstilling af 2-alkyl-4-(1-alkyl-4-piperidyliden)-benzocycloheptathiophenderivater eller syreadditionssalte deraf.
DK130830B (da) Analogifremgangsmåde til fremstilling af diphenylmethoxyethylaminer eller syreadditionssalte deraf.
DK137834B (da) Analogifremgangsmåde til fremstilling af triazolobenzodiazepinderivater eller syreadditionssalte deraf.
DK129715B (da) Analogifremgangsmåde til fremstilling af isoindolinderivater eller syreadditionssalte heraf.
DK134717B (da) Analogifremgangsmåde til fremstilling af substituerede m-dioxan-5-methylaminer eller syreadditionssalte deraf.
DK137796B (da) Fremgangsmåde til fremstilling af 1-aryloxy-3-aminopropanolderivater eller syreadditionssalte deraf.
DK134173B (da) Analogifremgangsmåde til fremstilling af benzomorphanderivater eller syreadditionssalte deraf.
DK132076C (da) Fremgangsmade til fremstilling af benzomorphanderivater ellerdisses syreadditionssalte